UK Signs Deal For 90 Million COVID-19 Vaccine Doses

The minister called on the British public to play their part in vaccine research through the new National Health Service (NHS) vaccine research register.

covid19

The UK government has signed deals for access to around 90 million doses of promising coronavirus vaccines under development, Business Secretary Alok Sharma announced here on Monday.

The senior Indian-origin Cabinet minister said the government has agreed significant partnerships with leading pharmaceutical and vaccine companies BioNTech/Pfizer and Valneva that are developing vaccines to protect people against the deadly coronavirus.

“The hunt to find a vaccine is a truly global endeavour and we are doing everything we can to ensure the British public get access to a safe and effective coronavirus vaccine as soon as possible,” Sharma said.

“This new partnership with some of the world’s foremost pharmaceutical and vaccine companies will ensure the UK has the best chance possible of securing a vaccine that protects those most at risk,” he said.

The minister called on the British public to play their part in vaccine research through the new National Health Service (NHS) vaccine research register.

“By signing up and participating in important clinical studies, together we can speed up the search for a vaccine and end the pandemic sooner,” he said.

As part of a number of pacts, the UK government says it has now secured access to three different types of COVID-19 vaccines that are being developed here and around the world, giving Britain the most likely chance of getting access to a safe and effective vaccine at the “quickest speed”.

It has also secured access to treatments containing COVID-19 neutralising antibodies from AstraZeneca to protect those who cannot receive vaccines, such as cancer and immunocompromised patients.

As a result of these partnerships, England, Scotland, Wales and Northern Ireland could have access to enough doses to vaccinate and protect priority groups identified, such as frontline health and social care workers and those at increased health risk, the Department for Business, Energy and Industrial Strategy (BEIS) said.

Facebook Comments